Related Experiment Video
Updated: Aug 24, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Effects of triethylene tetraamine on telomerase activity and proliferation in HeLa cells
Fei Yin1, Jianhui Liu, Xiaojun Peng
1State Key Laboratory of Fine Chemicals, Dalian University of Technology, 158 Zhong-shan Road, Dalian 116012, China.
Abstract:
Telomerase, which is required to maintain telomeres, has attracted considerable attention as a target for anticancer therapy. In this study, we investigated the inhibition of HeLa cell telomerase activity and cell cycle progression by triethylene tetraamine (TETA), using a modified telomeric repeat amplification protocol (TRAP) assay, and flow cytometry. TETA inhibited telomerase activity in HeLa cell extracts, with an IC50 of about 7.8 microM. Coupled with this inhibition, TETA also increased the proportion of cells in the G1 phase of the cell cycle in a dose-dependent manner. These findings demonstrate that TETA is a potent inhibitor of telomerase in micromolar concentrations, and inhibits the proliferation of HeLa cells by arresting them in G1.
Insights
Triethylene tetraamine (TETA) effectively inhibits HeLa cell telomerase activity and proliferation. This anticancer compound arrests cells in the G1 phase by targeting telomerase, showing promise in therapeutic applications.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Telomerase is crucial for maintaining telomeres and is a significant target in anticancer therapy.
- Understanding novel inhibitors of telomerase is vital for developing new cancer treatments.
Purpose of the Study:
- To investigate the inhibitory effects of triethylene tetraamine (TETA) on telomerase activity.
- To assess the impact of TETA on HeLa cell cycle progression.
Main Methods:
- Modified telomeric repeat amplification protocol (TRAP) assay to measure telomerase activity.
- Flow cytometry to analyze cell cycle distribution.
Main Results:
- Triethylene tetraamine (TETA) demonstrated significant inhibition of HeLa cell telomerase activity with an IC50 of approximately 7.8 microM.
- TETA treatment resulted in a dose-dependent increase in the proportion of cells arrested in the G1 phase.
- The compound effectively inhibited HeLa cell proliferation.
Conclusions:
- Triethylene tetraamine (TETA) is a potent telomerase inhibitor at micromolar concentrations.
- TETA inhibits HeLa cell proliferation by inducing G1 phase arrest.
- These findings support TETA as a potential candidate for anticancer drug development targeting telomerase.
Related Concept Videos
Telomeres and Telomerase
Replicative Cell Senescence
Mitogens and the Cell Cycle
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...

